FDA前疫苗部门负责人已加盟礼来公司

Core Insights - Eli Lilly's stock price saw a slight increase following reports that Peter Marks, the former head of the FDA's vaccine division, has joined the company [1] Company Summary - Eli Lilly (LLY) experienced a minor uptick in stock price on Tuesday [1] - The recruitment of Peter Marks, a notable figure from the FDA, is seen as a strategic move for Eli Lilly [1]